Intrace|lular protozoa, Leishmania spp, Trypanosoma cruzi, and Toxoplasma gondii, have as a pathogenic characteristic a particular tropism for host mononuclear phagocytes. Successful invasion of host macrophages (M4~) 1 by Leishmania promastigotes requires an initial interaction at the cell surface that has not been defined. In the presence of serum, enhanced binding ofLeishmania promastigotes to murine resident peritoneal M~b (RPM) is mediated by complement (1). In the absence of serum, the lectin-like Mq~-specific mannosyl/fucosyl receptor (MFR) may play a role (2), consistent with studies (3, 4) demonstrating mannose-rich glycoconjugates on the surface of L. donovani promastigotes. We report an additional role for the type three complement receptor (CR3) in serum-independent binding ofL. donovani to RPM. Modulation experiments in which either CR3 or MFR are rendered inaccessible demonstrate that both receptors must be present on the segment of M4~ membrane to which the parasite binds. The combined function of these two distinct M4~ receptors may represent a general mechanism for the entry of pathogenic protozoa into mononuclear phagocytes.
block all lymphocyte CR1 and CR2 rosetting (9) . The nucleophile, sodium salicyl hydroxamate, was prepared as a 100 mM solution in 100 mM NaOH and diluted in culture medium to 1 mM. Mannan (M7504) and ribonuclease B (type XIIB) (both from Sigma Chemical Co., St. Louis, MO) were used as MFR inhibitors at 1 mg/ml.
Parasites. Details of the isolation of L. donovani amastigotes from hamster spleen, and of the transformation and culture of promastigotes, appear elsewhere (2) . Promastigotes were used between days 3 and 7 of the 3rd to 17th subcultures, as indicated.
Mouse M4~. RPM were plated on washed, 13-mm glass coverslips (2) or on M1/70-, M 1/70-Fab-, mannan-, or 2.4G2-Fab-coated coverslips prepared by the method of Michl et al. (10) . The ability of Mq~ on coated coverslips to rosette iC3b-coated erythrocytes was assessed microscopically. Assays of 125I-mannose-bovine serum albumin uptake or M 1/70 binding by M4~ on mannan-or M 1/70-Fab-coated coverslips have been described (6) .
Parasite/Mck Binding. In each experiment, 5 x 10°promastigotes or 2.5 x 106 amastigotes were added to two or four coverslips, which were then washed and examined after 20 min. M4~ were scored individually (300-500 per coverslip) for attached and ingested parasites from Giemsa-stained fixed preparations (2) . M4~ were preincubated with soluble inhibitors for 15 min before and during the parasite incubation. Parasite binding to M4~ was examined in the absence of serum or with 8-12% normal or heat-inactivated (56°C, 30 rain) mouse serum (NMS or HINMS).
Alternative Pathway Activation. Consumption of complement in fresh human serum by promastigotes, amastigotes, and zymosan was compared (per parasite or particle) by a two-stage assay (11) . Alternative pathway activation was also measured for mannan (6.25 rag/m l), parasites in the presence of mannan (6.25 mg/ml), and mannan-coated coverslips.
Results and Discussion
The role of locally secreted complement proteins in mediating binding to Mq~ CR3 has already been established for the yeast wall product zymosan (6) . In initial experiments we examined the effects of the monoclonal anti-CR3 Ab M 1/ 70 on serum-independent binding and ingestion of L. donovani promastigotes and amastigotes by RPM. Fig. 1 A shows one experiment representative of 15 in which binding efficiency for control M4~ was 30-260 parasites per 100 cells in 20 min, depending on the promastigote subculture used, and for which 53-88% inhibition of promastigote binding and ingestion was observed in the continuous presence of soluble M1/70. In control experiments, similar inhibition of promastigote binding was obtained after preincubation alone with M1/70. The unrelated Ab F4/80 caused no inhibition of promastigote binding. It is unlikely, therefore, that the inhibition observed with M1/70 was simply due to steric hindrance. In four parallel experiments with amastigotes, binding efficiency in control Mq~ was 130-320 parasites per 100 cells in 20 min, but only 14-43% M1/70 inhibition was observed. This difference in ability to block binding of pro-and amastigotes with M 1/70 correlated with their relative abilities to activate the alternative pathway (Fig. 1B) and was mimicked by the use of the Fab fragment of anti-C3 Ab or the nucleophile, sodium salicyl hydroxamate (Fig.  I A) . Sodium salicyl hydroxamate is a potent inhibitor of the covalent binding of activated C3 to the activator surface (12) , providing strong evidence that cleaved C3, in the degraded iC3b form, on the surface of promastigotes mediates binding to CR3. Under similar assay conditions we have recently shown by sodium dodecyl sulfate-polyacrylamide gel analysis that M4~-derived cleaved C3 (iC3b) can be deposited on zymosan in the absence of exogenous complement (6 and Ezekowitz and Sim, unpublished results).
The present results establish a role for CR3 in the serum-independent binding of locally iC3b-opsonized promastigotes to the M~b surface. In view of our earlier observation (2) of MFR-mediated promastigote binding to RPM, we have determined the relative roles of these two receptors in parasite binding. A role for the MFR in uptake of zymosan has been demonstrated (13) and, in different M4) populations, additive effects of receptor blocking with mannan plus M 1/70 were observed (6) . In the present experiments (Fig. 2) , the use of mannan or ribonuclease B as soluble inhibitors of MFR-mediated binding resulted in similar inhibition to that with M1/70: promastigotes, 50-80%, amastigotes, ~30%. In no case was there any evidence for an additive effect of blocking the two receptors simultaneously. Mannan (6.25 mg/ml) did not itself consume alternative pathway components or inhibit the ability of the parasite to activate the alternative pathway. It was unlikely, therefore, that the effects of mannan or ribonuclease B were due to interference with or inhibition of CR3-mediated binding of the parasite. Rather, it appeared that each receptor played an equivalent role in binding and ingestion of the parasite. One explanation for the link between CR3 and MFR could be that they act sequentially, one receptor mediating attachment and the other promoting internalization. Our method of scoring parasites associated with MqS did not always allow us to distinguish these two functions. To clarify the roles of the two receptors, we performed additional experiments in which CR3 and MFR were selectively modulated onto M 1/70-Fab-or mannan-coated coverslips. M~b plated on M 1/70-Fab coverslips were unable to rosette iC3b-coated erythrocytes; specific binding of M 1/70 was <10% compared with M~b plated directly onto glass (12,133 ± 416 cpm 125I-labeled second stage Ab per coverslip). Specific uptake of 125I-mannose-BSA was equivalent to that of control M4) (6,980 ± 198 cpm/ coverslip during 20 min at 37°C). In the reciprocal experiment with cells plated on mannan-coated coverslips, iC3b-erythrocyte rosetting and binding of M 1/70 (12,600 ± 1,414 cpm/coverslip) was equivalent to that of control MqS, but uptake of ~25I-mannose-BSA was reduced by 71%. These experiments established that CR3 and MFR are distinct receptors whose function can be modulated independently. In experiments with parasites (Fig. 3) , equivalent reduction in binding and ingestion by M4~ was observed after modulation of either CR3 or MFR: promastigotes, ~80%, amastigotes, -60%. The addition of soluble inhibitors did not, in either case, enhance the inhibition. In control experiments, no inhibition of parasite binding was observed for M4~ where IgG2b/IgG 1 Fc receptors were modulated onto 2.4G2-Fab-coated coverslips, and mannan-coated coverslips did not activate the alternative pathway. These experiments demonstrate that, under serum-free conditions, both CR3 and MFR are required to promote attachment and ingestion of the parasite. Neither receptor alone is capable of performing even the lesser function of parasite attachment. Hence, an hypothesis based on sequential action of the two receptors is precluded, since at least one of them would be expected to bind the parasite. Nor does it appear that the remote signalling mechanisms described (14) for the combined action of fibronectin and complement receptors are operating. In that system, stimulation of the basal surface of monocyte plasma membranes by substrate-bound fibronectin was sufficient to activate complement receptors on the remote apical surface of the cell. In our studies, interaction of either CR3 or MFR with its respective surface-bound substrate (M1/70-Fab or mannan) was not sufficient to promote attachment and ingestion by the receptor accessible to the parasite on the upper surface of the M4). Apparently, both receptors must be present on the segment of membrane to which the parasite binds. This suggests some form of conformational co-recognition mechanism such as might occur if the same glycoconjugate molecule on the parasite surface were involved both in activating complement and in binding to MFR. Although earlier studies (3, 4) have shown mannose-rich glycoconjugates on the parasite surface, the covalent binding of activated C3 may be required to cause a necessary conformational change in the molecule, exposing the sugar residues that bind to MFR. As the MFR binds to this portion of the molecule, it may, in turn, promote maximal presentation of the binding site of iC3b to CR3. Further experiments are required to test these hypotheses.
As shown by others (1) 
CR3 IN SERUM-INDEPENDENT BINDING OF LEISHMAN1A
sufficient to mediate local opsonization of Leishmania and binding to CR3 that, in the absence of serum, requires the presence of an additional M4~ receptor, MFR. Although the precise mechanism for the combined action of these two receptors is not understood, the constitutive ability of M~ to produce complement components may play an important role in recognition and uptake of this and many other parasites known to activate the alternative pathway.
Summary
We have examined the relative roles of the macrophage (M40 plasma membrane receptor for the cleaved third complement component (iC3b, CR3) and of the mannosyl/fucosyl receptor (MFR) in binding and ingestion of Leishmania donovani. In the absence of exogenous complement, the binding and ingestion of promastigotes, which are good activators of the alternative complement pathway, were inhibited by the anti-CR3 monoclonal antibody M1/70, by the Fab portion of an anti-C3 antibody, or by the nucleophile, sodium salicyl hydroxamate, an inhibitor of C3 fixation. This provides strong evidence that Mq~-derived, cleaved C3 (iC3b) present on the promastigote surface mediates binding to CR3. Equivalent inhibition of promastigote binding and ingestion was also observed using the soluble inhibitors of MFR activity, mannan or ribonuclease B. No additive effect for blocking the two M4~ receptors simultaneously was observed. For amastigotes, which are poor activators of the alternative pathway, a lesser but nevertheless equivalent effect was observed for the three soluble inhibitors of CR3-mediated binding vs. the two soluble inhibitors of MFRmediated binding. Modulation experiments in which either CR3 or MFR had been rendered inaccessible demonstrated that both receptors must be present on the segment of M4~ membrane to which the parasite binds. The combined function of these two distinct M4~ receptors may provide a general mechanism for recognition and ingestion of other pathogenic protozoa known to activate the alternative pathway. 4 March 1985. 
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